Skip to main content
Zylox-Tonbridge Medical Technology Co., Ltd. logo

Zylox-Tonbridge Medical Technology Co., Ltd. — Investor Relations & Filings

Ticker · 2190 LEI · 254900QSIU3I0P3OEJ92 HKEX Manufacturing
Open in API
Filings indexed 513 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country CN China
Listing HKEX 2190

About Zylox-Tonbridge Medical Technology Co., Ltd.

http://www.zyloxtb.com

Zylox-Tonbridge Medical Technology Co., Ltd. is an integrated solution provider specializing in the research, development, and commercialization of neurovascular and peripheral vascular interventional medical devices. Recognized as a leading player in the market for high-value-added vascular medical devices, the company offers a comprehensive portfolio of revascularization products, including over 40 quality devices. Dedicated to advancing healthcare through cutting-edge technologies, Zylox-Tonbridge focuses on providing solutions for complex vascular conditions and is actively expanding its presence in the global medical technology market.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Regulatory Filings
2026-05-04 English
Next Day Disclosure Return
Regulatory Filings
2026-04-30 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return under Hong Kong Listing rules detailing on-market repurchases of the company’s own shares (number of shares repurchased, price, aggregate consideration, closing balances). It is a regulatory report of share buybacks/treasury share changes. This matches the “Transaction in Own Shares” category (share repurchase/issuance) rather than a broader regulatory notice or capital raising update. Therefore, it should be classified as POS.
2026-04-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) filed under Hong Kong Stock Exchange rules, detailing the issuer’s repurchase of its own ordinary H shares, changes in issued shares and treasury shares, repurchase prices, and confirmation of compliance. It is a direct reporting of the company’s share buyback activity (transaction in its own shares). This aligns with the “Transaction in Own Shares” category (Code: POS).
2026-04-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a regulatory disclosure (Exchange Form FF305) detailing changes in issued and treasury shares, including a share repurchase (treasury share acquisition) and related statistics, pursuant to Hong Kong Main Board/GEM listing rules. This is a report of the company’s own share transactions (buybacks and treasury share movements), matching the definition of Transaction in Own Shares (POS).
2026-04-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return filed under HKEX listing rules detailing share repurchases (Section I on treasury share changes and Section II repurchase report). It discloses the number of shares repurchased, prices, balances and confirmations about compliance. This is a report of the company’s transactions in its own shares (buybacks). It fits the definition of Transaction in Own Shares (Code: POS).
2026-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.